Cargando…

Clinical, Virological, Immunological, and Genomic Characterization of Asymptomatic and Symptomatic Cases With SARS-CoV-2 Infection in India

PURPOSE: The current global pandemic of coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), led to the investigation with clinical, biochemical, immunological, and genomic characterization from patients to understand the pathophysiology of vir...

Descripción completa

Detalles Bibliográficos
Autores principales: Chatterjee, Sanchari, Datey, Ankita, Sengupta, Soumya, Ghosh, Arup, Jha, Atimukta, Walia, Safal, Singh, Sharad, Suranjika, Sandhya, Bhattacharya, Gargee, Laha, Eshna, Keshry, Supriya Suman, Ray, Amrita, Pani, Sweta Smita, Suryawanshi, Amol Ratnakar, Dash, Rupesh, Senapati, Shantibhusan, Beuria, Tushar K., Syed, Gulam Hussain, Prasad, Punit, Raghav, Sunil Kumar, Devadas, Satish, Swain, Rajeeb K., Chattopadhyay, Soma, Parida, Ajay
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8724424/
https://www.ncbi.nlm.nih.gov/pubmed/34993157
http://dx.doi.org/10.3389/fcimb.2021.725035
_version_ 1784625904818847744
author Chatterjee, Sanchari
Datey, Ankita
Sengupta, Soumya
Ghosh, Arup
Jha, Atimukta
Walia, Safal
Singh, Sharad
Suranjika, Sandhya
Bhattacharya, Gargee
Laha, Eshna
Keshry, Supriya Suman
Ray, Amrita
Pani, Sweta Smita
Suryawanshi, Amol Ratnakar
Dash, Rupesh
Senapati, Shantibhusan
Beuria, Tushar K.
Syed, Gulam Hussain
Prasad, Punit
Raghav, Sunil Kumar
Devadas, Satish
Swain, Rajeeb K.
Chattopadhyay, Soma
Parida, Ajay
author_facet Chatterjee, Sanchari
Datey, Ankita
Sengupta, Soumya
Ghosh, Arup
Jha, Atimukta
Walia, Safal
Singh, Sharad
Suranjika, Sandhya
Bhattacharya, Gargee
Laha, Eshna
Keshry, Supriya Suman
Ray, Amrita
Pani, Sweta Smita
Suryawanshi, Amol Ratnakar
Dash, Rupesh
Senapati, Shantibhusan
Beuria, Tushar K.
Syed, Gulam Hussain
Prasad, Punit
Raghav, Sunil Kumar
Devadas, Satish
Swain, Rajeeb K.
Chattopadhyay, Soma
Parida, Ajay
author_sort Chatterjee, Sanchari
collection PubMed
description PURPOSE: The current global pandemic of coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), led to the investigation with clinical, biochemical, immunological, and genomic characterization from patients to understand the pathophysiology of viral infection. METHODS: Samples were collected from six asymptomatic and six symptomatic SARS-CoV-2-confirmed hospitalized patients in Bhubaneswar, Odisha, India. Clinical details, biochemical parameters, and treatment regimen were collected from a hospital; viral load was determined by RT-PCR; and the levels of cytokines and circulating antibodies in plasma were assessed by Bio-Plex and isotyping, respectively. In addition, whole-genome sequencing of viral strains and mutational analysis were carried out. RESULTS: Analysis of the biochemical parameters highlighted the increased levels of C-reactive protein (CRP), lactate dehydrogenase (LDH), serum SGPT, serum SGOT, and ferritin in symptomatic patients. Symptomatic patients were mostly with one or more comorbidities, especially type 2 diabetes (66.6%). The virological estimation revealed that there was no significant difference in viral load of oropharyngeal (OP) samples between the two groups. On the other hand, viral load was higher in plasma and serum samples of symptomatic patients, and they develop sufficient amounts of antibodies (IgG, IgM, and IgA). The levels of seven cytokines (IL-6, IL-1α, IP-10, IL-8, IL-10, IFN-α2, IL-15) were found to be highly elevated in symptomatic patients, while three cytokines (soluble CD40L, GRO, and MDC) were remarkably higher in asymptomatic patients. The whole-genome sequence analysis revealed that the current isolates were clustered with 19B, 20A, and 20B clades; however, 11 additional changes in Orf1ab, spike, Orf3a, Orf8, and nucleocapsid proteins were acquired. The D614G mutation in spike protein is linked with higher virus replication efficiency and severe SARS-CoV-2 infection as three patients had higher viral load, and among them, two patients with this mutation passed away. CONCLUSIONS: This is the first comprehensive study of SARS-CoV-2 patients from India. This will contribute to a better understanding of the pathophysiology of SARS-CoV-2 infection and thereby advance the implementation of effective disease control strategies.
format Online
Article
Text
id pubmed-8724424
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-87244242022-01-05 Clinical, Virological, Immunological, and Genomic Characterization of Asymptomatic and Symptomatic Cases With SARS-CoV-2 Infection in India Chatterjee, Sanchari Datey, Ankita Sengupta, Soumya Ghosh, Arup Jha, Atimukta Walia, Safal Singh, Sharad Suranjika, Sandhya Bhattacharya, Gargee Laha, Eshna Keshry, Supriya Suman Ray, Amrita Pani, Sweta Smita Suryawanshi, Amol Ratnakar Dash, Rupesh Senapati, Shantibhusan Beuria, Tushar K. Syed, Gulam Hussain Prasad, Punit Raghav, Sunil Kumar Devadas, Satish Swain, Rajeeb K. Chattopadhyay, Soma Parida, Ajay Front Cell Infect Microbiol Cellular and Infection Microbiology PURPOSE: The current global pandemic of coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), led to the investigation with clinical, biochemical, immunological, and genomic characterization from patients to understand the pathophysiology of viral infection. METHODS: Samples were collected from six asymptomatic and six symptomatic SARS-CoV-2-confirmed hospitalized patients in Bhubaneswar, Odisha, India. Clinical details, biochemical parameters, and treatment regimen were collected from a hospital; viral load was determined by RT-PCR; and the levels of cytokines and circulating antibodies in plasma were assessed by Bio-Plex and isotyping, respectively. In addition, whole-genome sequencing of viral strains and mutational analysis were carried out. RESULTS: Analysis of the biochemical parameters highlighted the increased levels of C-reactive protein (CRP), lactate dehydrogenase (LDH), serum SGPT, serum SGOT, and ferritin in symptomatic patients. Symptomatic patients were mostly with one or more comorbidities, especially type 2 diabetes (66.6%). The virological estimation revealed that there was no significant difference in viral load of oropharyngeal (OP) samples between the two groups. On the other hand, viral load was higher in plasma and serum samples of symptomatic patients, and they develop sufficient amounts of antibodies (IgG, IgM, and IgA). The levels of seven cytokines (IL-6, IL-1α, IP-10, IL-8, IL-10, IFN-α2, IL-15) were found to be highly elevated in symptomatic patients, while three cytokines (soluble CD40L, GRO, and MDC) were remarkably higher in asymptomatic patients. The whole-genome sequence analysis revealed that the current isolates were clustered with 19B, 20A, and 20B clades; however, 11 additional changes in Orf1ab, spike, Orf3a, Orf8, and nucleocapsid proteins were acquired. The D614G mutation in spike protein is linked with higher virus replication efficiency and severe SARS-CoV-2 infection as three patients had higher viral load, and among them, two patients with this mutation passed away. CONCLUSIONS: This is the first comprehensive study of SARS-CoV-2 patients from India. This will contribute to a better understanding of the pathophysiology of SARS-CoV-2 infection and thereby advance the implementation of effective disease control strategies. Frontiers Media S.A. 2021-12-21 /pmc/articles/PMC8724424/ /pubmed/34993157 http://dx.doi.org/10.3389/fcimb.2021.725035 Text en Copyright © 2021 Chatterjee, Datey, Sengupta, Ghosh, Jha, Walia, Singh, Suranjika, Bhattacharya, Laha, Keshry, Ray, Pani, Suryawanshi, Dash, Senapati, Beuria, Syed, Prasad, Raghav, Devadas, Swain, Chattopadhyay and Parida https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Cellular and Infection Microbiology
Chatterjee, Sanchari
Datey, Ankita
Sengupta, Soumya
Ghosh, Arup
Jha, Atimukta
Walia, Safal
Singh, Sharad
Suranjika, Sandhya
Bhattacharya, Gargee
Laha, Eshna
Keshry, Supriya Suman
Ray, Amrita
Pani, Sweta Smita
Suryawanshi, Amol Ratnakar
Dash, Rupesh
Senapati, Shantibhusan
Beuria, Tushar K.
Syed, Gulam Hussain
Prasad, Punit
Raghav, Sunil Kumar
Devadas, Satish
Swain, Rajeeb K.
Chattopadhyay, Soma
Parida, Ajay
Clinical, Virological, Immunological, and Genomic Characterization of Asymptomatic and Symptomatic Cases With SARS-CoV-2 Infection in India
title Clinical, Virological, Immunological, and Genomic Characterization of Asymptomatic and Symptomatic Cases With SARS-CoV-2 Infection in India
title_full Clinical, Virological, Immunological, and Genomic Characterization of Asymptomatic and Symptomatic Cases With SARS-CoV-2 Infection in India
title_fullStr Clinical, Virological, Immunological, and Genomic Characterization of Asymptomatic and Symptomatic Cases With SARS-CoV-2 Infection in India
title_full_unstemmed Clinical, Virological, Immunological, and Genomic Characterization of Asymptomatic and Symptomatic Cases With SARS-CoV-2 Infection in India
title_short Clinical, Virological, Immunological, and Genomic Characterization of Asymptomatic and Symptomatic Cases With SARS-CoV-2 Infection in India
title_sort clinical, virological, immunological, and genomic characterization of asymptomatic and symptomatic cases with sars-cov-2 infection in india
topic Cellular and Infection Microbiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8724424/
https://www.ncbi.nlm.nih.gov/pubmed/34993157
http://dx.doi.org/10.3389/fcimb.2021.725035
work_keys_str_mv AT chatterjeesanchari clinicalvirologicalimmunologicalandgenomiccharacterizationofasymptomaticandsymptomaticcaseswithsarscov2infectioninindia
AT dateyankita clinicalvirologicalimmunologicalandgenomiccharacterizationofasymptomaticandsymptomaticcaseswithsarscov2infectioninindia
AT senguptasoumya clinicalvirologicalimmunologicalandgenomiccharacterizationofasymptomaticandsymptomaticcaseswithsarscov2infectioninindia
AT ghosharup clinicalvirologicalimmunologicalandgenomiccharacterizationofasymptomaticandsymptomaticcaseswithsarscov2infectioninindia
AT jhaatimukta clinicalvirologicalimmunologicalandgenomiccharacterizationofasymptomaticandsymptomaticcaseswithsarscov2infectioninindia
AT waliasafal clinicalvirologicalimmunologicalandgenomiccharacterizationofasymptomaticandsymptomaticcaseswithsarscov2infectioninindia
AT singhsharad clinicalvirologicalimmunologicalandgenomiccharacterizationofasymptomaticandsymptomaticcaseswithsarscov2infectioninindia
AT suranjikasandhya clinicalvirologicalimmunologicalandgenomiccharacterizationofasymptomaticandsymptomaticcaseswithsarscov2infectioninindia
AT bhattacharyagargee clinicalvirologicalimmunologicalandgenomiccharacterizationofasymptomaticandsymptomaticcaseswithsarscov2infectioninindia
AT lahaeshna clinicalvirologicalimmunologicalandgenomiccharacterizationofasymptomaticandsymptomaticcaseswithsarscov2infectioninindia
AT keshrysupriyasuman clinicalvirologicalimmunologicalandgenomiccharacterizationofasymptomaticandsymptomaticcaseswithsarscov2infectioninindia
AT rayamrita clinicalvirologicalimmunologicalandgenomiccharacterizationofasymptomaticandsymptomaticcaseswithsarscov2infectioninindia
AT paniswetasmita clinicalvirologicalimmunologicalandgenomiccharacterizationofasymptomaticandsymptomaticcaseswithsarscov2infectioninindia
AT suryawanshiamolratnakar clinicalvirologicalimmunologicalandgenomiccharacterizationofasymptomaticandsymptomaticcaseswithsarscov2infectioninindia
AT dashrupesh clinicalvirologicalimmunologicalandgenomiccharacterizationofasymptomaticandsymptomaticcaseswithsarscov2infectioninindia
AT senapatishantibhusan clinicalvirologicalimmunologicalandgenomiccharacterizationofasymptomaticandsymptomaticcaseswithsarscov2infectioninindia
AT beuriatushark clinicalvirologicalimmunologicalandgenomiccharacterizationofasymptomaticandsymptomaticcaseswithsarscov2infectioninindia
AT syedgulamhussain clinicalvirologicalimmunologicalandgenomiccharacterizationofasymptomaticandsymptomaticcaseswithsarscov2infectioninindia
AT prasadpunit clinicalvirologicalimmunologicalandgenomiccharacterizationofasymptomaticandsymptomaticcaseswithsarscov2infectioninindia
AT raghavsunilkumar clinicalvirologicalimmunologicalandgenomiccharacterizationofasymptomaticandsymptomaticcaseswithsarscov2infectioninindia
AT devadassatish clinicalvirologicalimmunologicalandgenomiccharacterizationofasymptomaticandsymptomaticcaseswithsarscov2infectioninindia
AT swainrajeebk clinicalvirologicalimmunologicalandgenomiccharacterizationofasymptomaticandsymptomaticcaseswithsarscov2infectioninindia
AT chattopadhyaysoma clinicalvirologicalimmunologicalandgenomiccharacterizationofasymptomaticandsymptomaticcaseswithsarscov2infectioninindia
AT paridaajay clinicalvirologicalimmunologicalandgenomiccharacterizationofasymptomaticandsymptomaticcaseswithsarscov2infectioninindia